2,403
Views
48
CrossRef citations to date
0
Altmetric
Research Article

Preparation and therapeutic application of docetaxel-loaded poly(d,l-lactide) nanofibers in preventing breast cancer recurrence

, , , , , , , & show all
Pages 2677-2685 | Received 19 Apr 2015, Accepted 02 May 2015, Published online: 14 Jul 2015

Figures & data

Figure 1. SEM photographs of docetaxel (DTX)/PDLLA nanofibers containing (A) 0 wt%, (B) 5 wt% DTX/PDLLA, (C) 10 wt% DTX/PDLLA and (D) 20 wt% DTX/PDLLA (100 × and 5000×).

Figure 1. SEM photographs of docetaxel (DTX)/PDLLA nanofibers containing (A) 0 wt%, (B) 5 wt% DTX/PDLLA, (C) 10 wt% DTX/PDLLA and (D) 20 wt% DTX/PDLLA (100 × and 5000×).

Figure 2. WAXD patterns of (A) docetaxel (DTX), (B) blank PDLLA nanofibers, (C) 5 wt%. DTX/PDLLA, (D) 10 wt% DTX/PDLLA and (E) 20 wt% DTX/PDLLA nanofibers.

Figure 2. WAXD patterns of (A) docetaxel (DTX), (B) blank PDLLA nanofibers, (C) 5 wt%. DTX/PDLLA, (D) 10 wt% DTX/PDLLA and (E) 20 wt% DTX/PDLLA nanofibers.

Figure 3. Release profiles of docetaxel (DTX) from the DTX/PDLLA electrospun fibers.

Figure 3. Release profiles of docetaxel (DTX) from the DTX/PDLLA electrospun fibers.

Figure 4. In vitro cytotoxicity of the blank PDLLA and docetaxel (DTX)/PDLLA fibers to the 4T1 breast cancer cells after 24, 36, 48, 60 and 72 h of drug exposure.

Figure 4. In vitro cytotoxicity of the blank PDLLA and docetaxel (DTX)/PDLLA fibers to the 4T1 breast cancer cells after 24, 36, 48, 60 and 72 h of drug exposure.

Figure 5. Docetaxel (DTX) induced cell apoptosis on 4T1 breast cancer cells. Cells were treated with (A) blank control, (B) 5 wt% DTX/PDLLA, (C) 10 wt% DTX/PDLLA and (D) 20 wt% DTX/PDLLA, and stained with DAPI (blue). Apoptosis efficiency was evaluated. (E) Blank control without treatment, (F) 5 wt% DTX/PDLLA, (G) 10 wt% DTX/PDLLA and (H) 20 wt% DTX/PDLLA. Cells were stained with Annexin-V-FITC and propidium iodide (PI). Flow cytometry profile represented by Annexin-V-FITC staining on the X axis and PI on the Y axis.

Figure 5. Docetaxel (DTX) induced cell apoptosis on 4T1 breast cancer cells. Cells were treated with (A) blank control, (B) 5 wt% DTX/PDLLA, (C) 10 wt% DTX/PDLLA and (D) 20 wt% DTX/PDLLA, and stained with DAPI (blue). Apoptosis efficiency was evaluated. (E) Blank control without treatment, (F) 5 wt% DTX/PDLLA, (G) 10 wt% DTX/PDLLA and (H) 20 wt% DTX/PDLLA. Cells were stained with Annexin-V-FITC and propidium iodide (PI). Flow cytometry profile represented by Annexin-V-FITC staining on the X axis and PI on the Y axis.

Figure 6. The concentration measured via HPLC within plasma or tissues near the surgical site following implantation of DTX/PLA nanofibers or intravenous injection of an equivalent docetaxel dose. (A) DTX/PLA nanofibers result in higher docetaxel concentration in local tissue and (B) small quantities of DTX were detected in plasma.

Figure 6. The concentration measured via HPLC within plasma or tissues near the surgical site following implantation of DTX/PLA nanofibers or intravenous injection of an equivalent docetaxel dose. (A) DTX/PLA nanofibers result in higher docetaxel concentration in local tissue and (B) small quantities of DTX were detected in plasma.

Figure 7. Implantation of docetaxel (DTX)-loaded nanofibers prevents local recurrence. (A) Locally administrated DTX/PLA obviously reduced locoregional recurrence after resection of primary tumor (p < 0.05). (B) Overall survival was improved in the DTX/PDLLA group compared with all the other groups (p < 0.05).

Figure 7. Implantation of docetaxel (DTX)-loaded nanofibers prevents local recurrence. (A) Locally administrated DTX/PLA obviously reduced locoregional recurrence after resection of primary tumor (p < 0.05). (B) Overall survival was improved in the DTX/PDLLA group compared with all the other groups (p < 0.05).

Figure 8. Histological analysis of tissue response to the DTX/PDLLA nanofibers after (A) 2 weeks, (B) 4 weeks, (C) 6 weeks and (D) 8 weeks. There was a dense accumulation of inflammatory cells presented around the DTX/PDLLA fibrous scaffolds at week 2, which degraded over time and disappeared at week 8.

Figure 8. Histological analysis of tissue response to the DTX/PDLLA nanofibers after (A) 2 weeks, (B) 4 weeks, (C) 6 weeks and (D) 8 weeks. There was a dense accumulation of inflammatory cells presented around the DTX/PDLLA fibrous scaffolds at week 2, which degraded over time and disappeared at week 8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.